Format
Sort by

Send to

Choose Destination

Search results

Items: 16

1.

Spherical nanoparticle supported lipid bilayers for the structural study of membrane geometry-sensitive molecules.

Fu R, Gill RL Jr, Kim EY, Briley NE, Tyndall ER, Xu J, Li C, Ramamurthi KS, Flanagan JM, Tian F.

J Am Chem Soc. 2015 Nov 11;137(44):14031-4. doi: 10.1021/jacs.5b08303. Epub 2015 Oct 28.

PMID:
26488086
2.

Association of body composition and eating behavior in the normal weight obese syndrome.

Di Renzo L, Tyndall E, Gualtieri P, Carboni C, Valente R, Ciani AS, Tonini MG, De Lorenzo A.

Eat Weight Disord. 2016 Mar;21(1):99-106. doi: 10.1007/s40519-015-0215-y. Epub 2015 Sep 7.

PMID:
26347355
3.

Prodrugs of imidazotriazine and pyrrolotriazine C-nucleosides can increase anti-HCV activity and enhance nucleotide triphosphate concentrations in vitro.

Tyndall EM, Draffan AG, Frey B, Pool B, Halim R, Jahangiri S, Bond S, Wirth V, Luttick A, Tilmanis D, Thomas J, Porter K, Tucker SP.

Bioorg Med Chem Lett. 2015 Feb 15;25(4):869-73. doi: 10.1016/j.bmcl.2014.12.069. Epub 2014 Dec 30.

PMID:
25592710
4.

Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.

Draffan AG, Frey B, Fraser BH, Pool B, Gannon C, Tyndall EM, Cianci J, Harding M, Lilly M, Hufton R, Halim R, Jahangiri S, Bond S, Jeynes TP, Nguyen VT, Wirth V, Luttick A, Tilmanis D, Pryor M, Porter K, Morton CJ, Lin B, Duan J, Bethell RC, Kukolj G, Simoneau B, Tucker SP.

Bioorg Med Chem Lett. 2014 Nov 1;24(21):4984-8. doi: 10.1016/j.bmcl.2014.09.030. Epub 2014 Sep 21.

PMID:
25288185
5.

Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV Agents.

Draffan AG, Frey B, Pool B, Gannon C, Tyndall EM, Lilly M, Francom P, Hufton R, Halim R, Jahangiri S, Bond S, Nguyen VT, Jeynes TP, Wirth V, Luttick A, Tilmanis D, Thomas JD, Pryor M, Porter K, Morton CJ, Lin B, Duan J, Kukolj G, Simoneau B, McKercher G, Lagacé L, Amad M, Bethell RC, Tucker SP.

ACS Med Chem Lett. 2014 Apr 10;5(6):679-84. doi: 10.1021/ml500077j. eCollection 2014 Jun 12.

6.

Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors.

Axford LC, Agarwal PK, Anderson KH, Andrau LN, Atherall J, Barker S, Bennett JM, Blair M, Collins I, Czaplewski LG, Davies DT, Gannon CT, Kumar D, Lancett P, Logan A, Lunniss CJ, Mitchell DR, Offermann DA, Palmer JT, Palmer N, Pitt GR, Pommier S, Price D, Narasinga Rao B, Saxena R, Shukla T, Singh AK, Singh M, Srivastava A, Steele C, Stokes NR, Thomaides-Brears HB, Tyndall EM, Watson D, Haydon DJ.

Bioorg Med Chem Lett. 2013 Dec 15;23(24):6598-603. doi: 10.1016/j.bmcl.2013.10.058. Epub 2013 Nov 4.

PMID:
24239017
7.

Rapid and easy assessment of insulin resistance contributes to early detection of polycystic ovary syndrome.

Rizzo M, Tyndall EK, Frontoni S, Jacoangeli F, Sarlo F, Panebianco F, Mistorni A, Di Renzo L, Calafiore R, Luca G, De Lorenzo A.

J Endocrinol Invest. 2013 Jul-Aug;36(7):527-30. doi: 10.3275/8947. Epub 2013 Apr 23.

PMID:
23612476
8.

Aminoindoles, a novel scaffold with potent activity against Plasmodium falciparum.

Barker RH Jr, Urgaonkar S, Mazitschek R, Celatka C, Skerlj R, Cortese JF, Tyndall E, Liu H, Cromwell M, Sidhu AB, Guerrero-Bravo JE, Crespo-Llado KN, Serrano AE, Lin JW, Janse CJ, Khan SM, Duraisingh M, Coleman BI, Angulo-Barturen I, Jiménez-Díaz MB, Magán N, Gomez V, Ferrer S, Martínez MS, Wittlin S, Papastogiannidis P, O'Shea T, Klinger JD, Bree M, Lee E, Levine M, Wiegand RC, Munoz B, Wirth DF, Clardy J, Bathurst I, Sybertz E.

Antimicrob Agents Chemother. 2011 Jun;55(6):2612-22. doi: 10.1128/AAC.01714-10. Epub 2011 Mar 21.

9.

Antiplasmodial activity of piperazine sulfonamides.

Martyn DC, Cortese JF, Tyndall E, Dick J, Mazitschek R, Munoz B, Clardy J.

Bioorg Med Chem Lett. 2010 Jan 1;20(1):218-21. doi: 10.1016/j.bmcl.2009.10.130. Epub 2009 Oct 31.

PMID:
19914069
10.

Synthesis and antiplasmodial activity of novel 2,4-diaminopyrimidines.

Martyn DC, Nijjar A, Celatka CA, Mazitschek R, Cortese JF, Tyndall E, Liu H, Fitzgerald MM, O'Shea TJ, Danthi S, Clardy J.

Bioorg Med Chem Lett. 2010 Jan 1;20(1):228-31. doi: 10.1016/j.bmcl.2009.10.133. Epub 2009 Oct 31.

PMID:
19914064
11.

Synthesis and in vitro DMPK profiling of a 1,2-dioxolane-based library with activity against Plasmodium falciparum.

Martyn DC, Beletsky G, Cortese JF, Tyndall E, Liu H, Fitzgerald MM, O'Shea TJ, Liang B, Clardy J.

Bioorg Med Chem Lett. 2009 Oct 1;19(19):5657-60. doi: 10.1016/j.bmcl.2009.08.024. Epub 2009 Aug 8.

PMID:
19699641
12.

Genome-wide SNP genotyping highlights the role of natural selection in Plasmodium falciparum population divergence.

Neafsey DE, Schaffner SF, Volkman SK, Park D, Montgomery P, Milner DA Jr, Lukens A, Rosen D, Daniels R, Houde N, Cortese JF, Tyndall E, Gates C, Stange-Thomann N, Sarr O, Ndiaye D, Ndir O, Mboup S, Ferreira MU, Moraes Sdo L, Dash AP, Chitnis CE, Wiegand RC, Hartl DL, Birren BW, Lander ES, Sabeti PC, Wirth DF.

Genome Biol. 2008;9(12):R171. doi: 10.1186/gb-2008-9-12-r171. Epub 2008 Dec 15.

13.

Impact of molecular profiling on clinical trial design for glioblastoma.

Chakravarti A, Tyndall E, Palanichamy K, Mehta M, Aldape K, Loeffler J.

Curr Oncol Rep. 2007 Jan;9(1):71-9. Review.

PMID:
17164051
14.

Pedunculated pericardial coelomic cyst manifesting as a rolling intrapleural mass.

Shin MS, Tyndall EC, Ronderos AD.

Chest. 1973 Jan;63(1):123-4. No abstract available.

PMID:
4684098
15.

COLLECTION TECHNIQUES: A FIVE-YEAR COMPARISON.

TYNDALL EH Jr.

Hospitals. 1963 Dec 1;37:43-6 PASSIM. No abstract available.

PMID:
14104236
16.

ON THE AURORAL DISPLAY OF MAY 2, 1919.

Karrer E, Tyndall EP, Gavett GI.

Science. 1919 May 23;49(1273):495-7. No abstract available.

PMID:
17733142
Items per page

Supplemental Content

Loading ...
Write to the Help Desk